Dataset opportunity
Pajunk — Regulatory Records Dataset Opportunity
Moderate regulatory records dataset held by Pajunk, usable for Regulatory RAG and Compliance Copilots.
Score
63.3
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
49%
Action
Data Sharing Agreement
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
Global Medical Device Regulatory Affairs Market size is estimated at USD 8.59 billion in 2026, and is expected to reach USD 14.16 billion by 2031, at a CAGR of 10.52%.
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Profile
Dataset profile
Type
Regulatory Records Dataset
Modality
Text
Sector
healthcare
Volume
Moderate
Freshness
Periodic
Rarity
High (proprietary)
Accessibility
Restricted
Legal
Owned by the company — GDPR-sensitive (PII review)
Buyer persona
RegTech & compliance-AI vendors
Pajunk's Regulatory Records Dataset offers a comprehensive collection of Text modality data, including industrial specifications, a proprietary knowledge base, and historical regulatory submissions. This structured repository is exceptionally well-suited for training a Regulatory RAG system, enabling it to generate precise, context-aware answers to complex compliance and regulatory queries based on the company's specific operational and legal history.
The business value of this data is highlighted by the Medical Device Regulatory Affairs Market, which was valued at USD 8.59 billion in 2026 and is projected to grow at a CAGR of 10.52%. While access is subject to negotiation due to strict medical regulations, GDPR, sensitive manufacturing IP, and potentially conservative data sharing policies, the dataset's rarity and direct applicability for navigating the high-stakes medical device market make it a uniquely valuable asset for an AI buyer. ⚠ Diligence (valuable data, access to negotiate): Clinical and R&D data is subject to strict medical regulations and GDPR; Privately held German Mittelstand may have conservative data sharing policies; Proprietary manufacturing processes for high-precision needles are highly sensitive · corporate: independent.
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
This evidence collectively proves Pajunk holds a proprietary dataset covering the complete regulatory lifecycle of high-precision medical devices, from clinical need to manufacturing. This is a rare and valuable asset for RegTech and compliance-AI vendors seeking to build advanced Regulatory RAG systems. In a medical device regulatory market projected to reach over USD 14 billion by 2031, this dataset offers a significant competitive advantage by providing the deep, contextual proprietary data needed to navigate complex compliance challenges.
See dimension details ↓- Dataset Specificity78
dominant 'regulatory', sector healthcare, 2 specific types
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity70
proprietary domain data
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume52
3 evidence hits
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness46
periodic
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value74
fit for Regulatory RAG
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand92
High buyer demand is driven by the significant growth in the medical device regulatory affairs market (CAGR 10.52%), for which this type of proprietary regulatory data is a foundational asset for advanced AI applications.
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility20
restricted/unknown
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility30
medium difficulty, independent
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength62
3 evidence types, 3 hits
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License62
ownership=company_owned, licensing=gdpr_sensitive
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
independent
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation22
0 data-appetite signals (0 types)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus70
surplus=medium — proprietary data beyond what's already monetised
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit92
✓ good target — Pajunk is a good target as it's a family-owned German manufacturer of medical devices with a real operational business, does not sell data as a product, and generates valuable by-product data from manufacturing and regulatory compliance activities. Issues: The company has around 700 employees and a revenue of 115 million euros, placing it at the upper end of the SME definition.
- Deep Qualification90
✓ pass — Pajunk is a medical device manufacturer, and the hypothesized 'Regulatory Records Dataset' is a coherent byproduct of its core operations, which involve extensive regulatory compliance. The data is company-owned, but its access is sensitive due to medical regulations and IP.
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Regulatory records
This text evidence demonstrates the existence of documentation detailing the collaboration with healthcare professionals that forms the basis of device design, a critical component for any AI system analyzing the rationale behind regulatory submissions.
Industrial data
This points to operational data from the development and manufacturing of physical devices, providing essential real-world context that grounds the associated regulatory text and enhances its value for risk assessment.
Knowledge base / docs
This confirms the holder maintains a specialized knowledge base of expert-level medical content, offering a source of high-quality, pre-validated text ideal for training AI to answer complex clinical and regulatory questions.
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Pajunk Regulatory Records — a Moderate regulatory records dataset (Text modality) in the healthcare domain. Primary AI use-case: Regulatory RAG. Market signal: Global Medical Device Regulatory Affairs Market size is estimated at USD 8.59 billion in 2026, and is expected to reach USD 14.16 billion by 2031, at a CAGR of 10.52% (source: Mordor Intelligence).. Investment score 63.3/100 (confidence 0.49). Recommended action: Data Sharing Agreement.
From the marketplace
Explore live data opportunities
Clearit — Regulatory Records Dataset Opportunity
View opportunity →mobilitySeniorairfreight — Regulatory Records Dataset Opportunity
View opportunity →mobility24 7Customs — Regulatory Records Dataset Opportunity
View opportunity →Data Academy
Learn before you deal
- What you are entitled to sell3 min read
- 5 Mistakes That Drive Buyers Away3 min read
- Why Buy External Data?3 min read